-
Probenecid Workflows for Transport and Tumor Studies
2026-08-23
Probenecid supports controlled studies of MRP-mediated drug efflux, pannexin-1 signaling, and ischemia-associated neural injury. This practical guide connects transporter pharmacology with CD8+ T-cell immunometabolism while separating established evidence from hypothesis-generating assay extensions.
-
Recombinant Mouse M-CSF: Macrophage Workflows
2026-08-22
Build more consistent macrophage differentiation, metabolic profiling, and fibrosis-relevant assays with a defined mouse cytokine input. This practical guide shows how to use M-CSF without a tag while controlling dose, timing, phenotype drift, and assay variability.
-
Machine Learning Discovery of Senolytics
2026-08-22
The reference study shows that machine learning trained only on published screening data can identify senolytic candidates despite small and heterogeneous datasets. Computational screening followed by human-cell validation highlighted ginkgetin, periplocin, and oleandrin, providing a lower-cost framework for early-stage senolytic discovery.
-
WDR36, Glycolysis, and Human Trophectoderm Fate
2026-08-21
This study identifies WDR36 as a regulator of human blastoid formation and trophectoderm differentiation, linking the protein to glycolytic metabolism through its interaction with LDHA. Its combined mouse embryo, human blastoid, transcriptomic, and metabolomic design provides a mechanistic framework for studying early lineage commitment while also highlighting the limitations of blastoid models.
-
Candida krusei Apoptosis Pathways in Bovine Cells
2026-08-20
This study shows that the yeast and hypha phases of Candida krusei both trigger apoptosis in bovine mammary epithelial cells, but through biologically distinct mechanisms. Its phase-resolved co-culture design links yeast-associated injury to mitochondrial dysfunction and hypha-associated injury to death ligand/receptor signaling, while identifying TLR2/ERK and JNK/ERK as regulatory pathways.
-
Resveratrol, Autophagy, and Apoptosis in RCC 786-O Cells
2026-08-20
Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial damage and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while ROS-driven JNK activation stimulates protective autophagy. The study’s central implication is that autophagy inhibition may increase resveratrol sensitivity, although the evidence remains limited to an in vitro model.
-
ONX-0914: LMP7 Selectivity in Context
2026-08-19
ONX-0914 (PR-957) is a selective LMP7 inhibitor for dissecting immunoproteasome biology. This article explains why cell type, proteasome assembly, and assay timing determine how its cytokine and disease-model data should be interpreted.
-
Panobinostat (LBH589) Experimental Workflow Guide
2026-08-19
Build reproducible Panobinostat workflows that connect HDAC-driven chromatin changes with cell-cycle arrest and apoptosis. The guide also shows how to distinguish transcriptional consequences from active RNA Pol II-linked death signaling in cancer and drug-resistance models.
-
MnTBAP Chloride: From Redox Probe to Translation
2026-08-18
Mitochondrial superoxide is increasingly viewed as a mechanistic bridge between impaired energy metabolism, inflammation, and complex tissue phenotypes. This thought-leadership analysis examines how MnTBAP Chloride can help translational researchers test that bridge, using chronic stress and depression-like behavior as a model for moving from redox chemistry to biomarker-guided research.
-
ABT-263 (Navitoclax) Apoptosis Workflow Guide
2026-08-18
Build more informative Bcl-2 family inhibition experiments with ABT-263 (Navitoclax), from DMSO stock preparation through orthogonal apoptosis readouts. The workflow also adapts a state-stratified senescence model to help distinguish selective cell clearance from nonspecific toxicity.
-
Z-VDVAD-FMK in Apoptosis and Pyroptosis Assays
2026-08-17
Z-VDVAD-FMK is a cell-permeable, irreversible caspase-2–directed tool for separating mitochondrial apoptosis from downstream caspase signaling. This workflow also shows how to use it as a mechanistic comparator—not a caspase-1 substitute—when studying HOXC8-linked pyroptosis in lung cancer models.
-
Probenecid in Reliable Cell Assays
2026-08-17
Learn how Probenecid (SKU B2014) can help investigators distinguish transporter-mediated drug resistance from intrinsic cytotoxicity in cell-based assays. This scenario-driven guide covers formulation, controls, protocol optimization, interpretation, and practical vendor-selection criteria.
-
Chlamydial Vesicles Deliver OmpA to Mitochondria
2026-08-16
Mesesan et al. show that Chlamydia trachomatis uses bacteria-derived membrane vesicles to transport the β-barrel protein OmpA to host mitochondria, where it engages BAK and suppresses mitochondrial apoptosis. The study links vesicle-mediated organelle delivery to pathogen survival and provides a framework for distinguishing upstream mitochondrial control from downstream caspase activity inhibition.
-
Z-VAD-FMK Workflows for Apoptosis Research
2026-08-15
Build cleaner apoptosis experiments with Z-VAD-FMK, from caspase-dependence tests in THP-1 and Jurkat cells to mechanistic controls in small cell lung cancer models. The workflow also shows how to distinguish caspase-mediated apoptosis from ZBP1-associated, non-apoptotic cell death described in recent spliceosome research.
-
Q-VD-OPh Workflows for Caspase-Driven Cell Death
2026-08-14
Q-VD-OPh is a cell-permeable pan-caspase inhibitor for separating caspase-dependent apoptosis from lysosomal and other parallel death programs. This practical guide covers assay design, cryopreservation support, neurodegenerative disease models, dosing logic, and troubleshooting without treating caspase blockade as proof of a single death mechanism.